Standard operating procedures (SOPs) for palliative care. Presence and relevance of palliative SOPs within the network of German Comprehensive Cancer Centers (CCCs) funded by the German Cancer Aid

被引:0
|
作者
Stachura, P. [1 ,2 ]
Berendt, J. [1 ,2 ]
Stiel, S. [1 ,2 ]
Schuler, U. S. [2 ,3 ]
Ostgathe, C. [1 ,2 ]
机构
[1] Univ Klinikum Erlangen, Palliat Med Abt, Krankenhausstr 12, D-91054 Erlangen, Germany
[2] Deutsch Comprehens Canc Ctr, Arbeitsgrp Palliat Med Netzwerk, Dresden, Germany
[3] Univ Klinikum Carl Gustav Carus, Univ Palliat Ctr, Dresden, Germany
来源
SCHMERZ | 2017年 / 31卷 / 01期
关键词
Clinical pathway; Standard operating procedure; Palliative care; Quality; Comprehensive Cancer Center; LENGTH-OF-STAY; CLINICAL PATHWAYS; IMPLEMENTATION; GUIDELINES; OUTCOMES; IMPACT;
D O I
10.1007/s00482-016-0132-7
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Standard operating procedures (SOPs) can contribute to the improvement of patient care. Survey the presence and relevance of SOPs for palliative care (PC) within the network of German Comprehensive Cancer Centers (CCCs) funded by the German Cancer Aid. In a descriptive survey, palliative care services within 15 CCCs funded by the German Cancer Aid were asked to rate availability and thematic relevance of (1) symptom-related, (2) clinical pathways and (3) measures- and processes-oriented SOPs using a structured questionnaire. Pain management SOPs were the most common (n =11; 73 %). The most thematic relevance showed SOPs dedicated to pain management, care in the last days of life and delirium and other neuro-psychiatric diseases (each n =13; 87 %), followed by bowel obstruction, dyspnoea, nausea and palliative sedation (each n =12; 80 %). There is a wide gap between availability and perceived relevance of palliative care SOPs within the network of German CCCs funded by the German Cancer Aid. It is obvious that there is a need for further development of relevant SOPs in palliative care.
引用
收藏
页码:47 / 53
页数:7
相关论文
共 27 条
  • [21] Palliative care outpatients in a German comprehensive cancer center-identifying indicators for early and late referral
    Mueller, S.
    Fink, M.
    Hense, J.
    Comino, M. R. Salvador
    Schuler, M.
    Teufel, M.
    Tewes, M.
    BMC PALLIATIVE CARE, 2022, 21 (01)
  • [22] Predictors of outpatients' request for palliative care service at a medical oncology clinic of a German comprehensive cancer center
    Tewes, Mitra
    Rettler, Teresa
    Wolf, Nathalie
    Hense, Joerg
    Schuler, Martin
    Teufel, Martin
    Beckmann, Mingo
    SUPPORTIVE CARE IN CANCER, 2018, 26 (10) : 3641 - 3647
  • [23] Predictors of outpatients’ request for palliative care service at a medical oncology clinic of a German comprehensive cancer center
    Mitra Tewes
    Teresa Rettler
    Nathalie Wolf
    Jörg Hense
    Martin Schuler
    Martin Teufel
    Mingo Beckmann
    Supportive Care in Cancer, 2018, 26 : 3641 - 3647
  • [24] Zusammenarbeit von Intensivmedizin und PalliativmedizinEine Bestandsaufnahme an den deutschen onkologischen SpitzenzentrenCooperation between intensive care and palliative careThe status quo in German Comprehensive Cancer Centers
    J. Berendt
    C. Ostgathe
    S. T. Simon
    M. Tewes
    D. Schlieper
    M. Schallenburger
    S. Meier
    S. Gahr
    J. Schwartz
    M. Neukirchen
    Medizinische Klinik - Intensivmedizin und Notfallmedizin, 2021, 116 (7) : 586 - 594
  • [25] Palliativmedizin in onkologischen SpitzenzentrenRolle der von der Deutschen Krebshilfe geförderten AG PalliativmedizinPalliative medicine in oncology excellence centersRole of the palliative medicine working group funded by the German Cancer Aid
    Susanne Gahr
    Julia Berendt
    Mitra Tewes
    Forum, 2023, 38 (5) : 368 - 372
  • [26] Medication Safety in Patients Treated with New Oral Antitumor Agents: A Prospective, Randomized Investigation on the Impact of Intensified Clinical Pharmaceutical/Clinical Pharmacological Care on Patient Safety and Well-Being (AMBORA). Supported by the German Cancer Aid (70112447) within the Comprehensive Cancer Center Erlangen-EMN
    Schlichtiq, Katja
    Duerr, Pauline
    Fromm, Martin F.
    Doerje, Frank
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 137 - 137
  • [27] Medication safety in patients treated with new oral antitumor agents: A prospective, randomized investigation on the impact of intensified clinical pharmaceutical/clinical pharmacological care on patient safety, patient knowledge and patient well-being (AMBORA). Supported by the German Cancer Aid within the Comprehensive Cancer Center Erlangen-EMN
    Schlichtig, K.
    Lechner, P.
    Grafe, C.
    Ferstl, B.
    Fuchs, F.
    Hein, A.
    Meidenbauer, N.
    Sell, C.
    Semrau, S.
    Siebler, J.
    Pavel, M.
    Wullich, B.
    Neurath, M. F.
    Fietkau, R.
    Beckmann, M.
    Mackensen, A.
    Fromm, M. F.
    Dorje, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 198 - 198